| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.22 |
3e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
8e-05 |
| mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
9e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |